Skip to main navigation

en
fr
de

Overview
News & Events
Stock Info
Governance
Financial Info
IR Resources

Press Releases

News & Events

Press Releases
Corporate Events & Conferences
Presentations

Year

ABIVAX Reports New Preclinical Data Supporting ABX464 as HIV Functional Cure and Novel Treatment for Inflammatory Diseases at HIV DART Meeting

December 08, 2016

Read More

ABIVAX provides update on clinical development program for ABX464 for functional cure of patients with HIV-infection

December 06, 2016

Read More

ABIVAX to Host Key Opinion Leader Luncheon for Investors Focused on Novel Approaches to HIV Therapy

November 24, 2016

Read More

ABIVAX to Present Phase IIa Clinical Data on ABX464 during NIH/NIAID-Sponsored Strategies for an HIV Cure Meeting 2016

November 16, 2016

Read More

ABIVAX to Present at upcoming Investors Conferences

November 15, 2016

Read More

ABIVAX to Attend the Jefferies 2016 London Healthcare Conference

October 28, 2016

Read More

ABIVAX presented this week new pre-clinical data on ABX464 during scientific conference on “HIV Drug Therapy” in Glasgow, Scotland

October 27, 2016

Read More

ABIVAX annonce sa participation au salon Actionaria les 18 et 19 novembre 2016 à Paris

October 25, 2016

Read More

ABIVAX Announces R&D Day at Company’s New Collaborative Laboratory in Montpellier

October 11, 2016

Read More

Publication of a shareholder newsletter

October 04, 2016

Read More

Pagination

First page
Previous page
…
Page 20
Page 21
Current page 22
Page 23
Page 24
…
Next page
Last page

Investor Contact

Patrick Malloy
Head of Investor Relations

Email investors@abivax.com

Phone +1 847 987 4878

Subscribe to our Email Alerts

© 2024 All rights reserved by Abivax

Social Links

Twitter (opens in new window)
LinkedIn (opens in new window)

Search Investors

Search this site